Ko-3290 is an antagonist of β-adrenoceptor, with cardioselectivity and antilipolytic effects in animals.
[1]. T.H.PRINGLE, et al. The assessment of the-3-adrenoceptor blocking activity and cardioselectivity of Koe3290 innormal subjects. British Journal of Clinical Pharmacology (1987), 24(5), 581-9
















